Pear VC featured several portfolio developments this week, underscoring its focus on AI-driven healthcare and industrial innovation. The firm highlighted a $9 million seed round for Kin Health, a digital health startup building a free consumer platform to improve the physician‑patient conversation and bolster care adherence.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Kin Health, founded by physicians Arpan and Amit Parikh along with co‑founder Kyle Alwyn, targets the well‑documented problem of patients forgetting medical guidance after visits. Pear VC’s participation in the seed round expands its exposure to regulated digital health infrastructure aimed at patient engagement and workflow improvement.
Pear VC also spotlighted Valar Labs, an AI oncology diagnostics company using pathology slides to predict cancer treatment response and extend precision oncology to more patients. The firm referenced Valar’s prior $22 million Series A co‑led by DCVC and Andreessen Horowitz, signaling ongoing investor interest in clinically integrated AI tools with defined regulatory and commercial paths.
Beyond healthcare, Pear VC emphasized TruTec, a PearX W26 cohort company automating construction project estimation via computer vision applied to aerial imagery. Launched in January 2026 and already serving dozens of customers, TruTec targets a $17 billion annual market for largely manual estimation workflows, helping contractors bid on more projects without adding headcount.
The week’s updates also referenced Pear VC’s broader portfolio, including Paxos Health’s AI platform for insurance appeals, Greatly Health’s integrated cancer care model, Even Platforms’ modular robotic machine shops, and Quinn, an AI‑native commercial property insurance brokerage. Collectively, these moves highlight a strategy centered on AI, automation, and workflow optimization across healthcare, industrial, and insurtech segments.
For Pear VC, backing companies like Kin Health, Valar Labs, and TruTec may enhance diversification across high‑growth, technology‑enabled verticals while concentrating on products with clear use cases in complex workflows. Overall, the week underscored Pear VC’s continued build‑out of a sector‑diversified, AI‑anchored portfolio with an emphasis on clinically and operationally integrated solutions.